Impact BioMedical, Inc. (IBO)
0.453
-0.03
(-5.62%)
USD |
NYAM |
Aug 24, 16:00
0.4596
+0.01
(+1.46%)
After-Hours: 20:00
Impact BioMedical EPS Diluted (Quarterly) : -0.0065 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0065 |
| March 31, 2026 | -0.0212 |
| December 31, 2025 | 0.0501 |
| September 30, 2025 | -0.1206 |
| June 30, 2025 | -1.177 |
| March 31, 2025 | -0.105 |
| December 31, 2024 | -2.356 |
| September 30, 2024 | 0.3692 |
| June 30, 2024 | -0.0889 |
| March 31, 2024 | -0.0836 |
| December 31, 2023 | -0.1074 |
| September 30, 2023 | -0.101 |
| June 30, 2023 | -0.0958 |
| March 31, 2023 | -0.0571 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3071 |
| September 30, 2022 | -0.1885 |
| June 30, 2022 | -0.0636 |
| March 31, 2022 | -0.0582 |
| December 31, 2021 | 0.0276 |
| September 30, 2021 | -0.07 |
| June 30, 2021 | -0.0292 |
| March 31, 2021 | -0.0418 |
| December 31, 2020 | -0.0195 |
| September 30, 2020 | -0.0114 |
| June 30, 2020 | -0.0138 |
| March 31, 2020 | -0.0073 |
| September 30, 2019 | -0.0071 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | -0.7594 |
| LENZ Therapeutics, Inc. | -1.017 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.70M |
| Revenue (Quarterly) | 0.003M |
| Total Expenses (Quarterly) | 0.702M |
| Enterprise Value | 52.08M |
| Gross Profit Margin (Quarterly) | -9.40K% |
| Profit Margin (Quarterly) | -23.33K% |
| Earnings Yield | -21.68% |
| Normalized Earnings Yield | -23.93 |